AI-generated summary
The authors compared laser photobiomodulation pulpotomy with formocresol pulpotomy in primary molars of children aged 4 to 7 years, using a randomized split-mouth design. They report similar clinical success rates at 9 months, but a higher radiographic success rate in the laser group. The authors suggest laser photobiomodulation could be a viable nonpharmaceutical alternative, though the abstract's findings rest on a single trial.
- Participants
- 68
- Who or what was studied
- Children aged 4 to 7 years with at least two primary molars indicated for pulpotomy
- Limits stated in the abstract
- The abstract reports only a single randomized controlled trial with a 9-month follow-up and does not state wavelengths, dosing, or details of the laser protocol.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Randomized controlled trial, Low-level laser therapy, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.